People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Artes Medical CEO resigns: Aesthetic firm announces the resignation of founder and CEO Stefan Lemperle Nov. 27. The firm is being investigated by FDA's Office of Criminal Investigations for promoting and marketing Artecoll wrinkle filler prior to approval, according to a Nov. 7 Securities & Exchange Commission filing. The company previously acknowledged that former exec and co-founder Gottfried Lemperle, father of Stefan Lemperle, improperly used the product prior to approval. Chief Operating Officer Diane Goostree replaces the younger Lemperle as CEO. Artes received FDA approval of its next-generation wrinkle product ArteFill in October...